Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes
NCT02937805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225
Last updated 2018-07-02
Summary
Vulvovaginal atrophy is a common problem associated with decreased levels of estrogen. Typical symptoms include feelings of dryness and uncomfort of the mucous membranes of intimate area. The objective of this study is to investigate the effects of a non-hormonal moisturizing cream on symptoms and signs of vulvovaginal atrophy and dryness.
Conditions
- Vaginal Dryness
- Vaginal Atrophy
- Vulvar Dryness
- Vulvar Atrophy
Interventions
- DEVICE
-
Moisturizing vaginal and vulvar sea buckthorn oil cream
- DEVICE
-
Moisturizing vaginal and vulvar cream
Sponsors & Collaborators
-
Turun Gynekologikeskus Oy
collaborator UNKNOWN -
Tekes - The Finnish Funding Agency for Technology and Innovation
collaborator UNKNOWN -
Petra Larmo
lead INDUSTRY
Principal Investigators
-
Risto Erkkola, Professor · Turun Gynekologikeskus
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-07-31
- Completion
- 2017-09-30
Countries
- Finland
Study Locations
More Related Trials
-
Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women With Vaginal Atrophy
NCT06726746 ·Status: RECRUITING ·Phase: NA
-
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
NCT02859285 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
NCT04232813 ·Status: COMPLETED ·Phase: PHASE3
-
Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream
NCT02987647 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
NCT00361569 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.
NCT04657536 ·Status: UNKNOWN ·Phase: NA
-
Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis
NCT05118685 ·Status: UNKNOWN ·Phase: PHASE1
-
Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women
NCT01987804 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
NCT02195986 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
NCT02691936 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women
NCT03557398 ·Status: COMPLETED ·Phase: NA
-
Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Post-menopausal Women
NCT06808347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
NCT01122342 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women
NCT01432470 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
NCT00816556 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.
NCT02571127 ·Status: UNKNOWN ·Phase: PHASE4
-
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
NCT02460302 ·Status: WITHDRAWN ·Phase: PHASE2
-
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
NCT05586711 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
NCT03782480 ·Status: UNKNOWN ·Phase: PHASE3
-
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
NCT02670785 ·Status: COMPLETED ·Phase: PHASE2
-
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
NCT02013544 ·Status: COMPLETED ·Phase: PHASE3
-
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
NCT02449902 ·Status: COMPLETED ·Phase: PHASE2
-
Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women
NCT03281655 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
NCT01816139 ·Status: COMPLETED ·Phase: PHASE3
-
Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women
NCT02887885 ·Status: COMPLETED